Blog
RSS FeedPosted by Michael Wonder on 20 Mar 2025
Global pharma gives up reimbursement in Korea, and this is a serious concern
19 March 2025 - "We believe convincing our headquarters is no longer feasible, and we have no plans to apply ...
Posted by Michael Wonder on 18 Mar 2025
Pfizer's Ixifi will be available in Canada as of 1 April 2025
17 March 2025 - Ixifi is available in more than 20 countries and was approved by Health Canada in December 2021. ...
Posted by Michael Wonder on 17 Mar 2025
Government delivering even more choice for women's contraception, endometriosis, and IVF journeys
16 March 2025 - The Government is delivering even more choice for Australian women with new and amended listings for contraception, ...
Posted by Michael Wonder on 12 Mar 2025
PHARMAC to fund more cancer medicines (March 2025)
12 March 2025 - PHARMAC is funding six more medicines for cancers and one for antibiotic resistant infections. ...
Posted by Michael Wonder on 12 Mar 2025
Celltrion's infliximab, the first monoclonal antibody biosimilar, is now Remdantry in Canada
11 March 2025 - CT-P13, intravenous infliximab, developed and manufactured by Celltrion, is the first monoclonal antibody biosimilar therapy and has ...
Posted by Michael Wonder on 12 Mar 2025
ACCRUFeR (ferric maltol) is now available in Canada as a prescription oral treatment for iron deficiency anaemia
11 March 2025 - ACCRUFeR is the only oral iron therapy approved as a prescription drug in Canada. ...
Posted by Michael Wonder on 11 Mar 2025
PHARMAC funds new oral contraceptive pill
11 March 2025 - PHARMAC has decided to fund a new progestogen only oral contraceptive pill called desogestrel (Cerazette). ...
Posted by Michael Wonder on 10 Mar 2025
New insulin medicine proposed for people with diabetes
10 March 2025 - PHARMAC is seeking public feedback on a proposal to fund a new, additional type of insulin ...
Posted by Michael Wonder on 10 Mar 2025
Life changing new drug available for elderly Australians with devastating eye condition
9 March 2025 - A life changing new drug is now available on the PBS for elderly Australians with a ...
Posted by Michael Wonder on 09 Mar 2025
Expanded reimbursement for Rinvoq enhances atopic dermatitis treatment options
7 March 2025 - Korean patients with moderate to severe atopic dermatitis now have greater flexibility in treatment as reimbursement ...
Posted by Michael Wonder on 08 Mar 2025
This immunotherapy drug helped me beat cancer - instead of $229k it now costs $31
8 March 2025 - When she was just 26-years-old, Bianca Tesoriero’s life changed in an instant, following a visit to her ...
Posted by Michael Wonder on 05 Mar 2025
Skyrizi (risankizumab) now available for moderately to severely active ulcerative colitis, expanding AbbVie's portfolio across inflammatory bowel disease
4 March 2025 - Skyrizi is the first IL-23 specific inhibitor approved for both moderate to severe ulcerative colitis and ...
Posted by Michael Wonder on 05 Mar 2025
Obesity management needs medications on PBS: RACGP
4 March 2025 - The college’s new obesity position statement calls for extra funding to treat the complex condition and for ...
Posted by Michael Wonder on 04 Mar 2025
Roche Korea’s multiple sclerosis drug scores reimbursement
4 March 2025 - Roche Korea said its multiple sclerosis treatment, Ocrevus (ocrelizumab), started receiving reimbursement from last Saturday. ...
Posted by Michael Wonder on 03 Mar 2025
Amyloid cardiomyopathy drug Vyndamax to get health insurance from March
28 February 2025 - Vyndamax (tafamidis), a transthyretin amyloid cardiomyopathy medicine that has experienced difficulties getting on the health insurance ...